| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.02B | 17.15B | 12.92B | 11.40B | 11.01B | 11.98B |
| Gross Profit | 10.15B | 8.27B | 4.96B | 3.46B | 3.52B | 4.90B |
| EBITDA | 12.95B | 10.78B | 7.01B | 5.54B | 3.70B | 6.65B |
| Net Income | 6.09B | 5.08B | 2.14B | 1.27B | 432.00M | 2.02B |
Balance Sheet | ||||||
| Total Assets | 52.62B | 51.48B | 47.63B | 45.81B | 45.97B | 46.89B |
| Cash, Cash Equivalents and Short-Term Investments | 7.14B | 6.69B | 4.07B | 4.15B | 4.44B | 5.28B |
| Total Debt | 4.73B | 4.74B | 5.26B | 5.22B | 5.25B | 5.47B |
| Total Liabilities | 15.82B | 15.63B | 14.37B | 13.81B | 14.68B | 14.58B |
| Stockholders Equity | 27.36B | 26.51B | 24.29B | 23.34B | 22.77B | 23.86B |
Cash Flow | ||||||
| Free Cash Flow | 5.28B | 4.19B | 1.32B | 646.00M | 432.00M | 1.94B |
| Operating Cash Flow | 9.24B | 8.08B | 4.49B | 3.73B | 3.48B | 4.38B |
| Investing Cash Flow | -1.05B | -1.15B | -2.76B | -2.82B | -1.71B | -1.90B |
| Financing Cash Flow | -5.15B | -4.26B | -1.79B | -1.21B | -2.60B | -2.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | C$93.52B | 10.86 | 23.48% | 1.17% | 42.43% | 170.59% | |
79 Outperform | C$124.16B | 14.97 | 21.97% | 0.91% | 50.46% | 123.62% | |
78 Outperform | C$20.97B | 16.89 | 68.29% | 2.47% | 49.56% | 67.17% | |
76 Outperform | C$59.77B | 25.90 | 18.67% | 0.72% | 70.06% | 119.01% | |
72 Outperform | C$81.46B | 26.03 | 21.33% | 0.55% | 86.33% | 186.98% | |
71 Outperform | C$46.74B | 10.88 | 34.46% | 0.43% | 41.92% | 138.48% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |